Dry Eyes in Menopause: Why the Tear Film Changes After 45

Menopause is the common thread at this age, but dry eye has many contributors, and several are fixable.

Medications. Antihistamines and decongestants, diuretics, beta-blockers, antidepressants, sleeping aids and heartburn medications all reduce tear production or change its composition. Several of these are commonly started in the same years the transition begins, which is why a medication review comes before any hormonal explanation.

Autoimmune disease. Sjögren's disease attacks the moisture-producing glands and most often emerges in women in their forties and fifties. Dry eyes with a dry mouth, fatigue and joint aches is a pattern that should not be filed under menopause without a look at the immune system. Rheumatoid arthritis and lupus are also associated with dry eye, and thyroid disease can affect the eyelids and the surface of the eye.

Environment and habit. Screens reduce the blink rate, and hours of reading or driving do the same. Wind, smoke, air conditioning, heating vents and dry climates all speed evaporation. Contact lenses and a history of laser eye surgery are recognized risk factors.

An eye professional separates these at the slit lamp, by looking at the lid margins, the tear volume and the surface of the eye, and by asking about medications and systemic symptoms.

Dry eye is measured in the eye clinic, not in the blood. An examination assesses how much tear the eye produces, how quickly the film breaks up, whether the surface is damaged, and what the eyelid glands look like. Those measurements make the diagnosis and grade its severity, and a hormone level does none of that. Estradiol or testosterone results neither confirm dry eye nor predict it.

Blood work has a narrower role. When dry eyes arrive with a dry mouth, joint pain, fatigue or a rash, the antibodies associated with Sjögren's disease and inflammatory markers are the relevant tests, and thyroid function is worth knowing at the same time. That is a question a baseline panel can help with, and what blood work covers explains where those markers sit.

Eye pain, new sensitivity to light, a sudden change in vision, or one red eye needs same-day care from an eye professional, an urgent care clinic or an emergency department. None of those is a symptom of ordinary dry eye. They point to conditions such as infection of the cornea or inflammation inside the eye that can damage sight within days.

Dry eye symptoms that persist for more than a few weeks, that are getting worse, or that interfere with reading or driving should be seen at a routine eye appointment rather than managed indefinitely at home.

ACT 2 Health is a telehealth practice. There is no eye examination, no slit lamp and no imaging in an online visit. We can review medications, order blood work when systemic symptoms suggest an autoimmune or thyroid cause, and refer you to eye care. We screen and refer; we do not diagnose eye disease over a screen.

The intuition is reasonable: estrogen falls at menopause, dry eye begins, so replacing estrogen should help. The evidence does not support that, and in part it runs the other way.

The largest study to examine the question followed a large cohort of postmenopausal women in the Women's Health Study and found that those using hormone replacement therapy, and particularly estrogen alone, were more likely to have clinically diagnosed dry eye or severe symptoms than women who used none, with the association strengthening the longer the therapy had been used. The authors concluded that clinicians caring for women taking or considering hormone therapy should be aware of dry eye as a potential complication.

The proposed mechanism is the meibomian gland. Its oil production depends on androgens, and estrogen-dominant regimens can lower the androgen available to it, which may worsen the evaporative form of dry eye that dominates at midlife. The international TFOS DEWS II report on sex, gender and hormones reviews this evidence and describes the influence of estrogens on the ocular surface as complex, with androgens more consistently protective.

This does not make hormone therapy harmful for eyes, and the evidence is observational rather than settled. It does mean two things. Dry eye is not a reason to start hormone therapy, which is decided on other grounds and is covered on the women's hormone therapy page and in the HRT safety FAQ. And a woman who develops dry eye after starting or changing a regimen should mention it to her prescriber, because it belongs in the assessment rather than in the eye drops aisle. The wider list of symptoms that get missed at the transition is in the symptoms nobody warns you about.